eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update Portfolio News / Karina Tin March 8, 2023 eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update Read More »
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Portfolio News / Karina Tin March 8, 2023 Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Read More »
Revolution Medicines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Portfolio News / Karina Tin March 7, 2023 Revolution Medicines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Read More »